Trademark: 88810537
Status Date
Monday, October 30, 2023
Filing Date
Tuesday, February 25, 2020
Published for Opposition
Tuesday, April 4, 2023
5 pharmaceuticals and biopharmaceuticals for use in oncology, oncology supportive care and animal oncology; pharmaceuticals and biopharmaceuticals for use in urology; pharmaceuticals for use in benign prostatic hyperplasia and prostate enlargement
Nov 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 30, 2023
Sou Extension 1 Granted
Oct 30, 2023
Sou Extension 1 Filed
Oct 30, 2023
Sou Teas Extension Received
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 27, 2023
Approved For Pub - Principal Register
Feb 7, 2023
Teas/Email Correspondence Entered
Feb 7, 2023
Correspondence Received In Law Office
Feb 7, 2023
Assigned To Lie
Jan 31, 2023
Teas Response To Suspension Inquiry Received
Nov 28, 2022
Report Completed Suspension Check Case Still Suspended
Jun 29, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 29, 2022
Teas Change Of Correspondence Received
Jun 29, 2022
Teas Change Of Owner Address Received
Apr 25, 2022
Report Completed Suspension Check Case Still Suspended
Aug 20, 2021
Report Completed Suspension Check Case Still Suspended
Dec 2, 2020
Report Completed Suspension Check Case Still Suspended
Nov 30, 2020
Assigned To Lie
May 13, 2020
Notification Of Letter Of Suspension E-Mailed
May 13, 2020
Letter Of Suspension E-Mailed
May 13, 2020
Suspension Letter Written
May 13, 2020
Assigned To Examiner
Mar 4, 2020
New Application Office Supplied Data Entered
Feb 28, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
